For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Zeneca Limited

USPTO Granted Patents = 854

% Expired Patents = 1.1

CIPO Patents = 10

Trademarks = 24

Forward Citations = 10,926

Loading Chart...

Loading Chart...

884 inventors (with patents filed for the assignee):

Peter Gregory (39 out of 77 patents)

Stephen Martin Brown (23 out of 33 patents)

Scott Carson Miller (23 out of 25 patents)

4. Wolfgang Walter Schuch (22 out of 32 patents)

5. Ronald W Kenyon (21 out of 39 patents)

6. Martin Charles Bowden (18 out of 29 patents)

7. Roger Salmon (17 out of 41 patents)

8. Chris Allan Veale (17 out of 18 patents)

9. George R Brown (17 out of 40 patents)

10. Andrew John Barker (16 out of 23 patents)

11. Sarah Bronwen Rees (16 out of 20 patents)

12. Christopher R Godfrey (16 out of 67 patents)

13. Willem F Broekaert (16 out of 46 patents)

14. Peter R Bernstein (16 out of 27 patents)

15. Prahalad Manibhai Mistry (15 out of 30 patents)

Core Competencies:

Anticoagulants

Fungicides

Antibiotic Agents

Heterocycles

Prostaglandin Antagonists

Cytokine Inhibitors

Biocidal Proteins

Oxido-Squalene Cyclase Inhibitors

Angiogenesis Inhibitors

Monocyte Chemoattractant Protein-1

Flavoring Agents

Antifungal Proteins

854 patents: Sort by Forward Citations

1. 7173025 - Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents (2007-02-06),

2. RE38916 - APC Antibodies (2005-12-05),

3. 6953809 - Monocyte chemoattractant protein-1 inhibitor compounds (2005-10-11),

4. 6946468 - 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors (2005-09-20),

5. 6897214 - Quinazoline derivatives (2005-05-24),

6. 6897210 - Quinazoline derivatives and pharmaceutical compositions containing them (2005-05-24),

7. 6787562 - Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists (2004-09-07),

8. 6767571 - Flavoring agent from filamentous fungus (2004-07-27),

9. 6737424 - Alpha-substituted pyridazino quinoline compounds (2004-05-18),

10. 6730672 - Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents (2004-05-04),

11. 6686467 - Amide derivatives for the treatment of diseases mediated by cytokines (2004-02-03),

12. 6680183 - Production of optically active 2-substituted tetrahydropyran-4-ones (2004-01-20),

13. 6673803 - Quinazoline derivatives and pharmaceutical compositions containing them (2004-01-06),

14. 6608208 - Process for the preparation of 1,2-benzisothiazolin-3-ones (2003-08-19),

15. 6579553 - Flavoring materials from filamentous fungi (2003-06-17),

Zeneca Limited, headquartered in London, specializes in the development and manufacturing of innovative pharmaceutical products, particularly in the realm of heterocyclic compounds. The company focuses on a diverse array of therapeutic areas, including anticoagulants, fungicides, and antibiotic agents, leveraging advanced research in cytokine inhibitors and prostaglandin antagonists. Zeneca's commitment to scientific excellence positions it as a key player in the global pharmaceutical landscape, addressing critical health challenges through cutting-edge technology.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

854 Patents

#6 in London

#14 in United Kingdom

#1,167 in the World

London, United Kingdom

Zeneca Limited

Forward Citations = 10,926

884 inventors:

Peter Gregory (39 out of 77 patents)

Stephen Martin Brown (23 out of 33 patents)

Scott Carson Miller (23 out of 25 patents)

4. Wolfgang Walter Schuch (22 out of 32 patents)

5. Ronald W Kenyon (21 out of 39 patents)

Please report any incorrect information to [email protected]

Loading…